Meet Thesian Bio at BIO-Europe 2026 in Cologne
We will be at BIO-Europe in Cologne on 9 to 11 November, looking to meet partners and investors interested in in vivo cell therapy for solid tumors.
News
BioCentury Grand Rounds Europe 2026
Our team joined investors and industry leaders in Amsterdam to present our in vivo multi-immune cell CAR platform.
Thesian Bio awarded the i-Lab grant to advance multi-cell in vivo CAR therapy for solid tumors
The i-Lab competition has recognized our approach to in vivo multi-immune CAR therapy for solid tumors, and will support our preclinical work toward the clinic.